On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

The biotech industry faces a mix of longstanding and novel political challenges amid President Donald Trump’s second term.

IT's an incontrovertible fact that, as the political scientist John Mearsheimer, co-author of the landmark book, 'The Israel ...

Minimizes common user errors by up to 40% and enhances audit readiness by providing end-to-end traceability and data ...